Targeted pain relief from the earliest diagnosed stages of canine Osteoarthritis (OA)
Galliprant is a first-in-class prostaglandin receptor antagonist (PRA), a non-COX inhibiting NSAID. It specifically targets the EP4 receptor, the primary mediator of canine OA pain and inflammation1. You can start treatment from the earliest diagnosed stages. Give these dogs the relief they need and help keep them doing the things they love.
What is canine osteoarthritis?
Canine osteoarthritis is the most common cause of chronic pain in dogs2 and it doesn’t just occur in older, heavy dogs. It’s a painful disease that causes inflammation and swelling in a dog’s joints.
Early management and its benefits
Once pain sets in, a dog is less likely to move and may put on a few extra pounds. That can put more stress on joints and may lead to even more inflammation and pain. It’s a vicious cycle.
- Mode of action targets canine OA pain and inflammation while reducing the impact on GI, kidney and liver homeostasis1,3
- Suitable for dogs as young as 9 months of age
- Most dogs can be dosed with a whole or half tablet
- Please see Important Safety Information below
If you're a veterinarian, click here to learn more.
If you're a pet owner, click here to learn more.